December 29, 2014 3:11 AM ET

Biotechnology

Company Overview of Zalicus Inc.

Executive Profile

Daniel E. Furst M.D.

Member of Clinical Advisor for Immuno Inflammatory, Zalicus Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background

Dr. Daniel E. Furst, M.D. is the Carl M. Pearson Professor of Medicine at the University of California in Los Angeles (UCLA). Dr. Furst serves as Chairman of Rheumatology at UCLA and is responsible for developing Arthritis and Immunology Clinical Research. He serves as a Member of Clinical Advisor of Immuno-Inflammatory at CombinatoRx Inc. He serves as a Member of Scientific Advisory Board at arGentis Pharmaceuticals, LLC. He serves as a Member of Advisory Board at Horizon ...

Corporate Headquarters

245 First Street
Cambridge, Massachusetts 02142

United States

Phone: 617-301-7000
Fax: 617-301-7010

Board Members Memberships

There is no Board Members Memberships data available.

Education

MD
Johns Hopkins University
MD
Johns Hopkins School of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Zalicus Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.